The PI3K-Akt pathway promotes liver fibrosis through three key mechanisms: stimulating ECM production, activating hepatic stellate cells (HSCs), and inducing hepatic sinusoidal capillarization (Wang M. et al., 2022; Wang et al., 2019). The gene discussed is AKT1; the disease is Hepatic fibrosis.